PIN-5018

N/A

Report date: 2025/12/12 15:30:45
NME

Base Information

Drug NamePIN-5018
Drug Alias NamePIN-5018
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionCasein kinase I isoform alpha degraders
TargetsCasein kinase I isoform alpha
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantColorectal NeoplasmsCarcinoma, Adenoid Cystic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPin Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPin Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-ResistantColorectal NeoplasmsCarcinoma, Adenoid Cystic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A